Chiral is a technology company.
Chiral has raised $16.0M across 2 funding rounds.
Chiral has raised $16.0M in total across 2 funding rounds.
Chiral has raised $16.0M in total across 2 funding rounds.
Chiral's investors include Crane Venture Partners, Founderful, HCVC, Innosuisse, Quantonation, Astanor Ventures, Earlybird Venture Capital, First Round Capital, General Catalyst, Hardware Club, Night Capital.
Daicel Chiral Technologies (formerly Chiral Technologies, Inc.) is a leading provider of chiral chromatography solutions, specializing in the separation of optical isomers (enantiomers) for the pharmaceutical, agrochemical, and life science industries.[1][2][5] As a wholly-owned subsidiary of Japan's Daicel Chemical Industries, Ltd., the company offers the world's broadest portfolio of chiral stationary phases (CSPs), high-performance liquid chromatography (HPLC) and supercritical fluid chromatography (SFC) columns for analytical, semi-preparative, and preparative scales, plus custom separation services from method development to multi-kilogram purification.[1][2][3] It solves critical challenges in drug discovery, process development, and manufacturing single-enantiomer products, delivering durable, high-performance tools that reduce costs and enable previously impossible separations.[1][2]
The company maintains strong growth momentum through continuous innovation, such as immobilized CSPs (e.g., CHIRALPAK® IA™, IB™, IC™) for low-solubility compounds and 3-µm particle columns for high-throughput screening, while serving global markets via subsidiaries in North America (West Chester, PA) and Europe (Illkirch, France).[2][3][5]
Daicel Chiral Technologies traces its roots to Daicel Chemical Industries, Ltd., which pioneered the chiral chromatography industry nearly 40 years ago by developing polysaccharide-based CSPs that revolutionized enantiomer separation.[1][2] Established as Chiral Technologies, Inc. in West Chester, Pennsylvania, it became a wholly-owned subsidiary of Daicel, leveraging the parent company's fine chemicals expertise to expand into a global leader.[2][3][4] Key milestones include launching industry-standard columns, innovative immobilized phases for enhanced robustness, and bulk CSPs for process-scale use, with early focus on pharmaceutical needs driving rapid adoption in drug development.[1][2] This evolution from niche innovator to comprehensive service provider was propelled by unmatched technical expertise, enabling custom solutions for complex racemic resolutions.[1][5]
Daicel Chiral Technologies rides the wave of precision medicine and biologics, where enantiomer purity is essential for drug safety, efficacy, and regulatory approval amid rising demand for single-isomer therapeutics.[2][5] Timing aligns with SFC adoption for greener, faster separations over traditional HPLC, plus outsourcing trends in late-stage pharma development to cut timelines and costs.[1][2] Market forces like complex molecule pipelines and agrochemical innovation favor its expertise, influencing the ecosystem by enabling faster drug discovery—its columns and services underpin commercial single-enantiomer production worldwide.[1][3]
Next steps likely include expanding SFC capabilities, AI-driven method optimization, and larger-scale services to support gene therapy and novel modalities demanding ultra-pure isomers.[1][5] Trends like sustainable chromatography and personalized medicine will propel growth, potentially amplifying its influence through partnerships with CROs and big pharma. As the trusted chiral separation backbone, it remains pivotal for tomorrow's breakthroughs, echoing its legacy of turning separation impossibilities into industry standards.[1][2]
Chiral has raised $16.0M across 2 funding rounds. Most recently, it raised $12.0M Seed in February 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 5, 2026 | $12.0M Seed | Crane Venture Partners | Founderful, HCVC, Innosuisse, Quantonation |
| Feb 1, 2024 | $4.0M Seed | Astanor Ventures, Earlybird Venture Capital, First Round Capital, Founderful, General Catalyst, Hardware Club, Night Capital |